Apple Inc. (0R2V)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 346.34 |
|---|---|
| 52-week range | 244.69 – 351.75 |
| Return, 1 month / 3 months | +2.7% / +8.3% |
| Return, 1 year / 3 years | +33.7% / +103.2% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 25.5% |
| Worst drawdown (1 year) | -14.0% |
| Average daily value traded | 78.49M USD |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Apple Inc. designs, makes and sells consumer electronics, software and related services. Its main products include the iPhone smartphone, Mac computers, iPad tablets and wearable devices such as Apple Watch and AirPods, along with accessories. The company also provides services including the App Store, iCloud storage, Apple Music and Apple Pay. Its customers are individual consumers, businesses and developers around the world. Apple is based in Cupertino, California, in the United States.
On this site Apple Inc. appears as a stock on the London Exchange (UK), code 0R2V, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Apple Inc. (0R2V) trades on the London Exchange in UK. It last closed at USD 346.34 on 23 October 2026.
Its price-based Market X-Ray is 80 out of 100 (a strong price profile), ranking 64 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.7% and over the last three months it rose 8.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 88 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.5% | ||
| From 52-week high | -0.1% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.3% | ||
| 6-month return | 27.0% | ||
| 12-month return, skipping the last month | 30.2% | ||
| Stability (higher is calmer) | 81 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.0% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 78.49M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +2.7% |
| 3 months | +8.3% |
| 6 months | +27.0% |
| 1 year | +33.7% |
| 3 years | +103.2% |
| 5 years | +138.0% |
Signals
| 50-day / 200-day average | 329.74 / 294.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.32 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | USD 0.2700 |
| 11 May 2026 | USD 0.2700 |
| 9 Feb 2026 | USD 0.2600 |
| 10 Nov 2025 | USD 0.2600 |
| 11 Aug 2025 | USD 0.2600 |
| 9 May 2025 | USD 0.2600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.